Riskpilot← Back to searchSign inGet full accessJKN Medical Oy
OYDissolvedY-tunnus 2817119-4Urakkatie 21-PMedical specialists activities · NACE 8622Est. 2017— employees
Revenue 2025
EUR 543K
-8% vs 2024
EBITDA margin
-17.0%
-109% vs 2024
Equity ratio
84.1%
Financial strength
Net profit 2025
EUR -95K
-153% vs 2024
| Revenue | EUR 543K | -8% |
| EBITDA | EUR -92K | -109% |
| Net profit | EUR -95K | -153% |
| Total assets | EUR 509K | -20% |
| Equity | EUR 428K | -23% |
| Employees | — | — |
Legal name
JKN Medical Oy
Y-tunnus number
2817119-4
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
20. helmikuuta 2017
Share capital
EUR 2 500
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-11-30
Financial year
January – December
Company purpose
Lääkäripalvelujen tuottaminen potilaille, alan koulutus- ja konsultointipalvelujen tuottaminen, työnohjaus, luennointi sekä kustannustoiminta. Yhtiö voi omistaa, hallita ja vuokrata kiinteistöjä, liike- ja asuinhuoneistoja sekä kulkuneuvoja. Yhtiö voi harjoittaa arvopaperikauppaa.
Address
Urakkatie 21-P
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 306 | 500 | 546 | 592 | 543 |
| Staff expenses | −192 | −179 | −225 | 194 | −470 |
| EBITDA | 29 | 192 | 166 | 990 | −92 |
| Depreciation & amort. | −1 | −14 | −10 | 1 | −1 |
| EBIT | 28 | 178 | 156 | 221 | −93 |
| Net financials | −2 | −4 | −5 | 5 | 6 |
| Profit before tax | 26 | 174 | 151 | 223 | −95 |
| Tax | 6 | 35 | 31 | 45 | −0 |
| Net profit | 21 | 139 | 121 | 178 | −95 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 239 | 434 | 531 | 639 | 509 |
| Equity | 174 | 300 | 405 | 559 | 428 |
| Long-term debt | 61 | 96 | 85 | 55 | 52 |
| Short-term debt | 4 | 38 | 41 | 25 | 29 |
| Total debt | 65 | 135 | 126 | 80 | 81 |
EBITDA margin
-17.0%
This company
15.8%
Market median
-208% vs market
20212025
Equity ratio
84.1%
This company
38.2%
Market median
+120% vs market
20212025
Return on equity
-22.2%
This company
18.4%
Market median
-221% vs market
20212025
Net profit margin
-17.5%
This company
8.1%
Market median
-316% vs market
20212025
Asset turnover
1.07×
This company
1.12×
Market median
+4% vs market
20212025
Debt / equity
0.19×
This company
0.62×
Market median
+69% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2024-12-01 – 2025-11-30
- Annual report 2024Filed via PRH / YTJ · Period 2023-12-01 – 2024-11-30
- Annual report 2023Filed via PRH / YTJ · Period 2022-12-01 – 2023-11-30
- Annual report 2022Filed via PRH / YTJ · Period 2021-12-01 – 2022-11-30
- Annual report 2021Filed via PRH / YTJ · Period 2020-12-01 – 2021-11-30
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
JH Deputy Member | Deputy Member | 2017 |
JA | Audit | 2023 |
KK Deputy auditor | Deputy auditor | 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2017 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of JKN Medical Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jaakko Henrikki Keski-Nisula | Deputy Member | 0 companies |
| Jose Adam Juhani Kautonen | Audit | 0 companies |
| Kiri Kasperi Sopanen | Deputy auditor | 0 companies |
| Juho Artturi Keski-Nisula | Board of Directors | 0 companies |